Darunavir (Prezista) for HIV infection. [electronic resource]
Producer: 20061016Description: 74-5 p. digitalISSN:- 0025-732X
- Antiretroviral Therapy, Highly Active -- methods
- Biological Availability
- Blood Proteins -- metabolism
- Cytochrome P-450 CYP3A -- metabolism
- Cytochrome P-450 CYP3A Inhibitors
- Darunavir
- Drug Approval
- Drug Interactions
- Drug Resistance, Viral
- Enfuvirtide
- HIV Envelope Protein gp41 -- pharmacology
- HIV Infections -- drug therapy
- HIV Protease Inhibitors -- pharmacokinetics
- HIV-1 -- drug effects
- Humans
- Peptide Fragments -- pharmacology
- Protein Binding -- drug effects
- RNA, Viral -- blood
- Randomized Controlled Trials as Topic -- methods
- Ritonavir -- pharmacology
- Sulfonamides -- pharmacokinetics
- Tablets
- Time Factors
- United States
- Viral Load
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.